Cargando…
Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma
Autores principales: | Nemunaitis, John J, Linette, Gerald P, Hamid, Omid, Agarwala, Sanjiv S, Starodub, Alexander, Sun, Lei, Lebel, Francois, Barrett, John A, Lewis, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108925/ http://dx.doi.org/10.1186/1479-5876-12-S1-O11 |
Ejemplares similares
-
Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)
por: Daud, Adil, et al.
Publicado: (2015) -
Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma
por: Daud, Adil, et al.
Publicado: (2015) -
Role of IL-1b in NLRP12-associated autoinflammatory disorders and resistance to anti-IL-1 therapy
por: Jeru, Isabelle, et al.
Publicado: (2011) -
Regulation of angiogenesis by angiostatin through immune cells and IL 12 production
por: Noonan, Douglas M, et al.
Publicado: (2006) -
Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23 synthesis
por: Fox, D, et al.
Publicado: (2003)